Search Results - "GERL, A"

Myocardial infarction and other major vascular events during chemotherapy for testicular cancer by Dieckmann, K.-P., Gerl, A., Witt, J., Hartmann, J.-T.

“…Chronic vascular morbidity resulting from chemotherapy for testicular germ-cell cancer (TGCC) is recognized. Cardiovascular events (CVEs) occurring early…”
Get full text

Intermediate prognosis in metastatic germ cell tumors (IPGCT): Outcome and prognostic stratification by Seidel, C., Daugaard, K.G., Tryakin, A., Necchi, A., Cohn Cedermark, G., Ståhl, O., Hentrich, M., Brito, M., Albany, C., Taza, F., Gerl, A., Oechsle, K., Oing, C., Bokemeyer, C.

Get full text

High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis by Beyer, J., Stenning, S., Gerl, A., Fossa, S., Siegert, W.

“…Background The purpose of this study was to compare high-dose chemotherapy (HDCT) with conventional-dose chemotherapy (CDCT) as first-salvage treatment in…”
Get full text

Activity of Oxaliplatin in Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer: A Study of the German Testicular Cancer Study Group by KOLLMANNSBERGER, C, RICK, O, SPOTT, C, KANZ, L, BOKEMEYER, C, DERIGS, H.-G, SCHLEUCHER, N, SCHÖFFSKI, P, BEYER, J, SCHOCH, R, SAYER, H. G, GERL, A, KUCZYK, M

“…To investigate the efficacy and toxicity of oxaliplatin, a diaminocyclohaxane platinum derivative with incomplete cross-resistance to cisplatin in patients…”
Get full text

Salvage Treatment With Paclitaxel, Ifosfamide, and Cisplatin Plus High-Dose Carboplatin, Etoposide, and Thiotepa Followed by Autologous Stem-Cell Rescue in Patients With Relapsed or Refractory Germ Cell Cancer by RICK, O, BOKEMEYER, C, HARTMANN, F, SCHMOLL, H. J, DERIGS, G, GERL, A, BERDEL, W. E, KANZ, L, SIEGERT, W, BEYER, J, HARTMANN, J. T, SCHWELLA, N, KINGREEN, D, NEUREITHER, S, METZNER, B, CASPER, J, WANDT, H

“…To study feasibility and efficacy of a new salvage regimen in patients with relapsed and/or refractory germ cell tumors. Between May 1995 and February 1997, 80…”
Get full text

Gemcitabine in Patients With Relapsed or Cisplatin-Refractory Testicular Cancer by BOKEMEYER, C, GERL, A, SCHÖFFSKI, P, HARSTRICK, A, NIEDERLE, N, BEYER, J, CASPER, J, SCHMOLL, H. J, KANZ, L

“…Despite generally high cure rates in patients with metastatic testicular germ cell tumors, patients with incomplete response to cisplatin-based first-line…”
Get full text

Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials by BOKEMEYER, C, KOLLMANNSBERGER, C, KANZ, L, OLIVER, T, STENNING, S, HARTMANN, J. T, HORWICH, A, CLEMM, C, GERL, A, MEISNER, C, RÜCKERL, C.-P, SCHMOLL, H.-J

“…To study the role of single agent carboplatin chemotherapy in patients with metastatic seminoma based on the data from two randomised trials. In subgroup…”
Get full text

Late relapse of germ cell tumors after cisplatin-based chemotherapy by Gerl, A., Clemm, C., Schmeller, N., Hentrich, M., Lamerz, R., Wilmanns, W.

“…Background: Sparse data are available with regard to the incidence, clinical characteristics, therapeutic management and prognosis of male patients with germ…”
Get full text

Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors by Hartmann, J. T., Nichols, C. R., Droz, J.-P., Horwich, A., Gerl, A., Fossa, S. D., Beyer, J., Pont, J., Kanz, L., Einhorn, L., Bokemeyer, C.

“…Background: This investigation evaluates prognostic variables in patients with seminomatous and non-seminomatous extragonadal germ-cell tumors (EGCT) in order…”
Get full text

Successful salvage high-dose chemotherapy and autologous stem-cell transplantation in HIV-related germ-cell tumor by Hentrich, M., Schiel, X., Niedermeier, A., Lutz, L., Rupec, R., Stief, C., Bogner, J., Karthaus, M., Gerl, A.

Get full text

Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors by HARTMANN, J. T, NICHOLS, C. R, KANZ, L, BOKEMEYER, C, DROZ, J.-P, HORWICH, A, GERL, A, FOSSA, S. D, BEYER, J, PONT, J, FIZAZI, K, EINHORN, L

“…The association between primary germ cell tumors of the mediastinum (the space between the lung pleura that contains the heart and other chest viscera) and…”
Get full text

Second-Line Chemotherapy in Patients With Relapsed Extragonadal Nonseminomatous Germ Cell Tumors: Results of an International Multicenter Analysis by HARTMANN, Jörg T, EINHORN, Lawrence, KANZ, Lothar, BOKEMEYER, Carsten, NICHOLS, Craig R, DROZ, Jean-P, HORWICH, Alan, GERL, Arthur, FOSSA, Sophie D, BEYER, Jörg, PONT, Jörg, SCHMOLL, Hans-J

“…Relapsed extragonadal germ cell tumors patients (EGGCT) are treated with identical salvage chemotherapy regimens, as are patients with metastatic testicular…”
Get full text

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours by FOSS, S. D, STENNING, S. P, MEAD, G. M, CULLEN, M. H, KAYE, S. B, RUSTIN, G. J. S, COOK, P. A, GERL, A, HORWICH, A, CLARK, P. I, WILKINSON, P. M, JONES, W. G, WILLIAMS, M. V, OLIVER, R. T, NEWLANDS, E. S

“…The aim of this study was to define prognostic parameters for survival in patients with malignant germ cell tumours progressing after platinum-based induction…”
Get full text

Subjective quality of life and sexual functioning after germ-cell tumour therapy by FEGG, M. J, GERL, A, VOLLMER, T. C, GRUBER, U, JOST, C, MEILER, S, HIDDEMANN, W

“…To evaluate the influence of germ-cell tumour therapy on sexual functioning and subjective quality of life (QL). To investigate the communication about sexual…”
Get full text

Vascular toxicity associated with chemotherapy for testicular cancer by Gerl, A

“…Cisplatin-based chemotherapy considerably improved the outcome of patients with metastatic germ cell tumors. Apart from Raynaud's phenomenon, a frequent side…”
Get more information

Incidence of Metachronous Testicular Cancer in Patients With Extragonadal Germ Cell Tumors by Hartmann, Jörg T., Fossa, Sophie D., Nichols, Craig R., Droz, Jean-Paul, Horwich, Alan, Gerl, Arthur, Beyer, Jörg, Pont, Jörg, Fizazi, Karim, Hecker, Hartmut, Kanz, Lothar, Einhorn, Lawrence, Bokemeyer, Carsten

“…Background: The frequency of subsequent testicular cancer (referred to as metachronous testicular cancer) in men who have had previous testicular cancer is…”
Get full text

Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer by Steyerberg, E W, Gerl, A, Fossá, S D, Sleijfer, D T, de Wit, R, Kirkels, W J, Schmeller, N, Clemm, C, Habbema, J D, Keizer, H J

“…To validate predictions of the histology (necrosis, mature teratoma, or cancer) of residual retroperitoneal masses in patients treated with chemotherapy for…”
Get more information

Outcome of patients with metastatic germ cell cancer treated between 2000 and 2013 at two centers in Munich by Gerl, A., Debole, J., Hentrich, M.

Get full text

Prognosis after salvage treatment for unselected male patients with germ cell tumours by GERL, A, CLEMM, C, SCHMELLER, N, HARTENSTEIN, R, LAMERZ, R, WILMANNS, W

“…Long-term outcome of salvage treatment was reviewed in 67 unselected male patients relapsing during or after their primary cisplatin-based chemotherapy for…”
Get full text

Outcome analysis after post-chemotherapy surgery in patients with non-seminomatous germ cell tumours by Gerl, A, Clemm, C, Schmeller, N, Dienemann, H, Lamerz, R, Kriegmair, M, Wilmanns, W

“…The goal of the study was to analyse long-term outcome after post-chemotherapy surgery in male patients with non-seminomatous germ cell tumours (NSGCT). We…”
Get more information